Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Beginning Cash Balance: 2009-2024

Historic Beginning Cash Balance for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $18.3 million.

  • Cumberland Pharmaceuticals' Beginning Cash Balance fell 7.21% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year decrease of 5.64%. This contributed to the annual value of $18.3 million for FY2024, which is 7.27% down from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Beginning Cash Balance stood at $18.3 million, which was down 7.27% from $19.8 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Beginning Cash Balance peaked at $28.2 million during FY2020, and registered a low of $18.3 million during FY2024.
  • Moreover, its 3-year median value for Beginning Cash Balance was $19.8 million (2023), whereas its average is $21.7 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Beginning Cash Balance increased by 9.24% in 2022, and later decreased by 26.93% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Beginning Cash Balance (Yearly) stood at $28.2 million in 2020, then dropped by 12.26% to $24.8 million in 2021, then climbed by 9.24% to $27.0 million in 2022, then decreased by 26.93% to $19.8 million in 2023, then declined by 7.27% to $18.3 million in 2024.